FEATURED EDITORIAL
Induced pluripotent stem cells (iPSCs) are generated by reprogramming adult somatic cells into a pluripotent state, meaning they can develop into any cell type in the human body. This has tremendous potential in regenerative medicine and gene therapy.
- Tracking The Latest Developments In CAR T Safety And Efficacy
- Araris Doubles Down With Dual-payload ADC
- AI Is A Tool — Not A Replacement — For Human Innovation In Drug Discovery
- Does Targeting Macrophages Hold The Key For Treating Cancer?
- Great siRNA Science Or Savvy Business Acumen? You Need Both
- The Search For A Chemotherapy-Free Treatment For Patients With Blood Cancer
- Bridge RNAs: Principles, Applications, And Challenges
FEATURED APPLICATION CONTENT
-
Explore two innovative technologies that address major purification challenges in DSP: continuous multi-column chromatography and advanced chromatography or liquid chromatography-mass spectrometry.
-
Issues related to cleaning and cleaning validation are some of the most common concerns that arise in FDA Warning Letters. Discover how to ensure you pass your cleaning validation tests.
-
Discover the innovative methods behind CAR-T cell production, from custom plasmid design to lentiviral vector transduction, and explore their potential in revolutionizing cancer treatment.
-
Explore the results of a study focusing on the early stages of the CAR T cell workflow, specifically the initial washing of leukapheresis followed by the isolation of T cells.
-
Discover how you can achieve a final mAb concentration above 200 g/L while maintaining critical quality attributes.
-
Learn about a rapid, high-throughput method for determining the E/F ratio in the AAV drug product that is well-suited for screening both crude and purified AAV samples.
-
Gain insight into how a high-throughput capsid assay for rapid AV quantification was developed using an innovative Bio-Layer Interferometry (BLI) platform that offers high precision and reliability.
-
Examine the performance of a biosensor for AAV capsid titer measurement that offers high-precision, broad AAV serotype binding specificity, and more.
-
To address concerns about using organic solvents in the ADC process, extractables studies were conducted on a disposable chromatography column housing and two different disposable flow paths.
-
What steps is the biopharma industry taking to enhance sustainability? What challenges does biopharma encounter? And how can the entire industry draw lessons from the companies setting the standard?
-
A healthcare manufacturer facing space constraints and regulatory pressures outsourced their stability storage needs to another company, resulting in reduced costs and focus on core competencies.
-
When facing a malfunction, having an effective disaster recovery plan can make the difference between a swift fix, and losing your samples and time.
FEATURED NEWS HEADLINES
- A New Framework To Efficiently Screen Drugs
- Scripps Research Scientists Discover Chemical Probes For Previously 'Undruggable' Cancer Target
- Innovation At A Price: The Hidden Costs Of Antibiotic Development
- UroGen Announces FDA Acceptance Of Its New Drug Application For UGN-102
- For The First Time, A Drug Developed At UWM Enters FDA Clinical Trials
- Alleo And Ubiquigent Enter AI-Driven Strategic Partnership To Accelerate DUB-Focused Drug Discovery
- Lantern Pharma's Investigational Drug-Candidate, LP-184, Receives Fast-Track Designation In Glioblastoma From The FDA
- SystImmune, Inc. Announces FDA Clearance Of IND Application For BL-M11D1 In Relapsed/Refractory Acute Myeloid Leukemia
- Eurofins Discovery Extends AI-Powered Integrated Drug Discovery Collaboration
- A Look Into 'Mirror Molecules' May Lead To New Medicines
ARCHIVED NEWSLETTER
- 10.18.24 -- Resources For Trouble-Free Validation
- 10.16.24 -- Revolutionizing Pharma: Storage, Disaster Recovery, and Nitrosamine Solutions
- 10.16.24 -- Curious About Diverse Antibodies?
- 10.15.24 -- Araris Doubles Down With Dual-payload ADC
- 10.08.24 -- Tips For Addressing Vaccine Demand – No Matter Your Therapeutic Background